CPG,
Like most old timers here, I always believe and still believe BTA has the products to be the next CSL save for GSK and the parasites on board.
BTA price will move if more parasites leave the board or on the announcement of more pandemic stockpile order. Chances of the parasites leaving is extremely remote and as to the later, anyone’s opinion is just guess work in the current economic uncertainties.
The next GSK report in April will indicate how the UK order is travelling. GSK is keeping the details from BTA like some form of trade secret which contrast sharply to idiots claiming relationship had normalised from the cooked settlement. IF no new orders are announced and the GSK April report is dismal, BTA share price could take a hit.
Having said this, there is money to be made in BTA for share traders and seasoned investors and even more money for seasoned pump-and-dump gurus. To borrow a cliché, this is not a share for risk adverse investor. For me the jury is still out and I have not wrote off BTA as accused by some of the HC pumpers.
Good luck CPG.
- Forums
- ASX - By Stock
- h1n1 heading down under
CPG,Like most old timers here, I always believe and still...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online